跳至主要内容
临床试验/NCT02350972
NCT02350972已完成1 期

Inducing Systemic Immunity and Regressions in Metastatic Melanoma

NYU Langone Health0 个研究点目标入组 88 人开始时间: 2015年1月30日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
88
主要终点
Immune responses as evidenced by lymphocytic infiltrates in never-injected nodules.

研究概览

简要总结

In patients with multiple metastatic nodules of melanoma, the investigators evaluated whether autologous cytokines injected into cutaneous metastases would induce a systemic immune response as evidenced by the accumulation of dense lymphocytic infiltrates in metastases that had never been injected. Such immune responses were observed, and often the never-injected metastasis regressed completely. 20% of patients remained free of disease for greater than 5 years.

详细描述

Lymphocytic infiltrates were seen in never-injected nodules only after several weeks of injections elsewhere. No adverse events were seen. The tumor-infiltrating lymphocytes were able to kill autologous melanoma ex vivo. Some patients who experienced complete regressions of all metastases lived without disease for over 10 years.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
21 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Multiple cutaneous or subcutaneous metastases of melanoma

排除标准

  • Visceral metastases on admission.
  • No current chemotherapy or immunotherapy.
  • Note study performed between 1978 and 2002 before current therapies were available.

结局指标

主要结局

Immune responses as evidenced by lymphocytic infiltrates in never-injected nodules.

时间窗: Cutaneous nodules were biopsied by a surgeon afer 8 to 20 weeks of injections.

The biopsies were examined by a licensed pathologist for the presence of dense lymphocytic infiltrates.

次要结局

  • Complete regression of a metastasis(Complete regressions of all injected and never-injected metastases occurred in different pts after 13 weeks to 48 months of injections. Pts with progressive disease were switched to chemotherapy at any point in the study.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fred T. Valentine

Professor of Medicine

NYU Langone Health

相似试验

Inducing Systemic Immunity and Regressions in... | 临床试验